It is comprised of basic, translational, and clinical researchers whose diverse research programs focus on Type 1 and Type 2 diabetes, diabetes complications, and autoimmunity. The DRC facilitates their research endeavors by providing efficient and innovative shared resources, developing enrichment programs to facilitate interactions and collaborations between center members, and implementing a strong pilot and feasibility program to bring new investigators into the diabetes field. These efforts result in an improved understanding of disease etiologies and progression and promote the development of diabetes treatments and cures.
Led by Director Dr. Lori Sussel, PhD, and Co-director Dr. Jane Reusch, MD, the UC DRC is dedicated to advancing diabetes research and improving outcomes for individuals living with diabetes. Located on the Anschutz Medical Campus in Aurora, Colorado, the UC DRC serves as a hub for groundbreaking diabetes research, benefiting from the collaborative environment of the University of Colorado's clinical and research departments.
At CU DRC, we foster alliances between diabetes basic and translational researchers throughout the state of Colorado and in the US. We partner with complementary research programs relevant to diabetes and many of the CU basic science departments. Our partnerships drive innovation, facilitate knowledge exchange, and create opportunities for groundbreaking research that addresses challenges in diabetes.
We are committed to nurturing the next generation of researchers and innovators. Through our Pilot & Feasibility (P&F) program, we provide essential mentorship and opportunities to emerging talents. This program offers guidance, support, and invaluable industry insights to help develop future leaders in the field. Our approach combines hands-on experience with expert mentorship, ensuring that promising researchers receive the tools and knowledge they need to excel in their careers and contribute significantly to scientific advancement.
CU DRC is at the forefront of cutting-edge research, pushing the boundaries of scientific knowledge. Our team of dedicated researchers explores novel ideas, develops new technologies, and conducts studies that contribute to advancements in diabetes research.
We actively seek and provide funding opportunities to support promising research initiatives through our Pilot & Feasibility (P&F) program. Our resource allocation strategy ensures that innovative projects receive the financial backing and resources necessary to transform ideas into impactful solutions.